Showing 1,021 - 1,040 results of 10,612 for search '"real life"', query time: 0.24s Refine Results
  1. 1021

    Ceft-to-Ceft Study: Real-Life Experience with Ceftaroline and Ceftobiprole in Treatment of the Principal Infectious Syndromes in a Spanish Multicenter Hospital Cohort by Daniel Arnés García, Inés Pitto-Robles, Jorge Calderón Parra, Marina Calvo Salvador, Carmen Herrero Rodríguez, Laura Gisbert, Carmen Hidalgo-Tenorio

    Published 2023-12-01
    “…Background: To compare the real-life effectiveness and safety of ceftaroline fosamil (ceftaroline-F) and ceftobiprole medocaril (ceftobiprole-M) for infections in hospitalized patients. …”
    Get full text
    Article
  2. 1022
  3. 1023
  4. 1024
  5. 1025
  6. 1026
  7. 1027
  8. 1028
  9. 1029

    Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study by Pelaia C, Ferrante Bannera A, Rotundo FL, Tropea FG, Armentaro G, Maglio A, Sciacqua A, Vatrella A, Pelaia G

    Published 2023-05-01
    “…In particular, the reported changes of mMRC/CAT scores and COPD exacerbation numbers were significantly correlated with UMEC/VI–induced modifications of TLC, RV, FVC and FEV1.Conclusion: In conclusion, our study corroborates in a real-life context the effectiveness of UMEC/VI in COPD treatment. …”
    Get full text
    Article
  10. 1030
  11. 1031

    A new cure model that corrects for increased risk of non-cancer death: analysis of reliability and robustness, and application to real-life data by Laura Botta, Juste Goungounga, Riccardo Capocaccia, Gaelle Romain, Marc Colonna, Gemma Gatta, Olayidé Boussari, Valérie Jooste

    Published 2023-03-01
    “…When applied to colon cancer real-life data, cure fractions estimated using the proposed model were higher than those in the conventional model, e.g. 5% higher in males at age 60 (57% vs. 52%). …”
    Get full text
    Article
  12. 1032

    A Real-Life Survey of Venous Thromboembolic Events Occurring in Myeloma Patients Treated in Third Line with Second-Generation Novel Agents by Valeria Calafiore, Silvia Giamporcaro, Concetta Conticello, Alessandra Romano, Marina Parisi, Gaetano Giuffrida, Daniele Tibullo, Francesco Di Raimondo, Salvatore Santo Signorelli

    Published 2020-09-01
    “…No VTE occurred in patients treated with daratumumab. Thus, our real-life experience documents that (1) in RRMM patients treated with continuative regimens of third line, the incidence of VTE is similar to the setting of newly-diagnosed patients; (2) many patients in real-life received prophylaxis with ASA, irrespective of the risk classification; (3) the IMPEDE VTE score seems to be more appropriate to define the risk categories. …”
    Get full text
    Article
  13. 1033
  14. 1034
  15. 1035

    Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study by Myrto Nikoloudaki, Myrto Nikoloudaki, Dionysis Nikolopoulos, Sofia Koutsoviti, Irini Flouri, Irini Flouri, Noemin Kapsala, Argyro Repa, Argyro Repa, Pelagia Katsimbri, Evangelos Theotikos, Sofia Pitsigavdaki, Sofia Pitsigavdaki, Katerina Pateromichelaki, Katerina Pateromichelaki, Antonios Bertsias, Antonios Bertsias, Antonia Elezoglou, Prodromos Sidiropoulos, Prodromos Sidiropoulos, Prodromos Sidiropoulos, Antonis Fanouriakis, Antonis Fanouriakis, Dimitrios Boumpas, Dimitrios Boumpas, George Bertsias, George Bertsias, George Bertsias

    Published 2023-01-01
    “…Although severe flares were reduced, flares were not uncommon (58.0%) and contributed to treatment stops (odds ratio [OR] 1.73 per major flare; 95% CI 1.09-2.75) and damage accrual (OR 1.83 per mild/moderate flare; 95% CI 1.15-2.93).ConclusionsIn a real-life setting with predominant long-standing SLE, belimumab was effective in the majority of patients, facilitating the achievement of therapeutic targets. …”
    Get full text
    Article
  16. 1036
  17. 1037

    Impact of Anti-IL5 Therapies on Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study by Susana Rojo-Tolosa, María Victoria González-Gutiérrez, Gonzalo Jiménez-Gálvez, José Antonio Sánchez-Martínez, Laura Elena Pineda-Lancheros, José María Gálvez-Navas, Alberto Jiménez-Morales, Cristina Pérez-Ramírez, Concepción Morales-García

    Published 2023-01-01
    “…The objective of this study was to evaluate, in real life, the clinical improvement of patients with SUA treated with anti-interleukin 5 (IL5) therapies: mepolizumab and benralizumab, together with the search for biomarkers associated with the response. …”
    Get full text
    Article
  18. 1038
  19. 1039

    Bleeding complications with clopidogrel or ticagrelor in ST-elevation myocardial infarction patients – A real life cohort study of two treatment strategies by Joakim Alfredsson, Kime Omar, József Csog, Dimitrios Venetsanos, Magnus Janzon, Mattias Ekstedt

    Published 2020-04-01
    “…Larger studies are needed to determine whether bleeding complications off-sets benefits with a more potent DAPT strategy in older and more comorbid real-life patients. Keywords: Myocardial infarction, Ticagrelor, Clopidogrel, Bleeding complications…”
    Get full text
    Article
  20. 1040